|
Doubt cast on LABA withdrawal in combination asthma therapy
News-Medical.net By Caroline Price, Senior medwireNews Reporter. Researchers have urged doctors to be cautious over withdrawal of long-acting beta-2 agonist (LABA) therapy in patients with asthma controlled by this type of bronchodilator in combination with an inhaled … |
View full post on asthma – Google News